AstraZeneca

AstraZeneca

Nanologica is involved in a partner project with AstraZeneca. The project is a continuation of an earlier successful in vitro evaluation project. The aim of the project is to evaluate if Nanologica’s platform can improve the formulation of one of AstraZeneca’s APIs and includes in vitro as well as pre-clinical in vivo studies.